Navigation Links
Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award
Date:4/18/2011

COVINGTON, Ky., April 18, 2011 /PRNewswire/ -- Bexion Pharmaceuticals was named the Biotech Innovation Award winner at the Cincinnati USA Innovation Awards program sponsored by the Cincinnati Business Courier, the Cincinnati USA Regional Chamber and CincyTech.  The Innovation Awards celebrate outstanding innovation and the companies and people who have shown how new ideas can be developed into fuel for the regional Tri-State (Ohio/Kentucky/Indiana) economic engine.

"The Bexion team is honored to be the very first winner of the Biotech Innovation Award," stated Dr. Ray Takigiku, co-founder and CEO of Bexion.  "Cancer treatment and diagnosis is in dire need of innovation.  We believe, and the award judges appear to agree, that our approach represents an entirely new, exciting and potentially paradigm-shifting approach to the treatment of cancer."

Bexion is developing BXQ-350 nanovesicles as a potential treatment for the form of brain cancer called glioblastoma.  BXQ-350 nanovesicles have an affinity for the membrane patches that are common in many types of tumor cells including glioblastoma cells. Bexion's studies have shown effectiveness in the laboratory in multiple animal tumor models, and across a remarkable range of tumors in the test tube.

About Bexion Pharmaceuticals:Bexion Pharmaceuticals is focused on the development and commercialization of innovative cures for cancer.  Initial products are based on a patent-protected and proprietary platform technology licensed from Cincinnati Children's Hospital Medical Center.  The technology has demonstrated potential for development as therapeutics, diagnostics and surgical imaging reagents, as well as carriers for other pharmaceutical agents, such as oligonucleotides.  For more information, visit www.bexionpharma.com.For media enquiries contact:

For investor enquiries contact:Margaret van GilseChuck Scheper
'/>"/>

SOURCE Bexion Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Former FDA Commissioner Joins Bexion Pharmaceuticals Board
2. Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
3. Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
4. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
5. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
6. Amylin Pharmaceuticals Reports First Quarter Financial Results
7. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
8. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
9. Endo Pharmaceuticals to Announce First Quarter 2011 Financial Results on April 28, 2011
10. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
11. Novis Pharmaceuticals Celebrates Four Years With New Website Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation (NYSE: ... directors has approved a quarterly dividend of $0.275 (27.5 cents) ... payable on August 1, 2014, to holders of record on ... CVS Caremark is dedicated to helping people on their ... in the United States . Through the ...
(Date:1/15/2014)... and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental ... order to treat dental impairments, for tooth restoration and ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... Semafore Pharmaceuticals Inc.,announced today on the occasion of ... Conference in San Francisco that its,integrin-targeted PI3 kinase ... agents in vitro and in vivo (poster,C207). ... of prostate cancer cells with combinations of docetaxel ...
... IRVINE, Calif., Oct. 26 IDM Pharma, Inc.,(Nasdaq: ... the development of,innovative cancer therapies, today announced details ... pipeline compounds to be,presented at upcoming medical congresses. ... Mifamurtide (L-MTP-PE):, Connective Tissue Oncology Society (CTOS) ...
Cached Medicine Technology:Semafore's PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents 2IDM Pharma Announces Upcoming Clinical Data Presentations 2IDM Pharma Announces Upcoming Clinical Data Presentations 3IDM Pharma Announces Upcoming Clinical Data Presentations 4
(Date:7/10/2014)... July 10, 2014 One week ahead ... Worker Safety announced today it will extend compensation benefits ... months’ wages for workers displaced as a result of ... Alliance inspections have resulted in the closure of five ... five cases, raising immediate safety concerns. In May, the ...
(Date:7/10/2014)... 2014 According to a new ... Platforms (Land, Airborne, Naval), Application (Software Defined Radios, ... Geography (North America, Asia-Pacific, Europe, the Middle East ... by MarketsandMarkets, the market is estimated to be ... register a CAGR of 5.56% to reach $39.52 ...
(Date:7/10/2014)... In his latest blog post at http://www.perwickstrom.com , ... Wickstrom has listed 5 ways to follow-up without being ... get information or sometimes even just return an inquiry, ... a skill that most people don’t have,” commented Per ... dialogue moving without coming across as annoying – let ...
(Date:7/10/2014)... Creek, MI (PRWEB) July 10, 2014 ... alcohol treatment program that gets clients off to a ... recovery they can believe in, has launched a new ... , The new section highlights:, , ... Diagnostic and Statistic Manual of Mental Disorders (DSM-IV), including ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Ivalua, ... latest results of the 4th “Trending in Procurement” ... model. , Every day multinational corporations process ... expense forms etc. To meet this challenge, more ... suites which can be defined as a suite ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety to Double Compensation for Displaced Factory Workers; Members Vote to Extend Wage Benefits from Two to up to Four Months 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Per Wickstrom’s Latest Blog Post Lists 5 Ways to Follow-up Without Being Annoying 2Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 3
... Hospitality Solutions with Pro:Idiom , Enable MSOs to ... R.L. Drake , an American ... highly innovative communications solutions for over 65 years, has ... cable transcoders to cable operators in the United States ...
... April 1, GlaxoSmithKline (NYSE: GSK ... regulatory applications to expand the use of TYVERB(R)/TYKERB(R) ... as a first-line therapy regimen combined with anti-hormonal ... breast cancer in Europe and the United States.The ...
... low-level shoulder separations can commonly be treated nonsurgically and ... in the April 2009 issue of the Journal ... JAAOS ) finds that many surgeons still disagree on ... fall in between. , , Shoulder separations, clinically ...
... an important contribution to future clinical therapeutic approaches. The ... Nature and will be a central topic of ... which will take place in Munich from April 2nd ... mechanisms of blood formation (hematopoiesis) will be presented in ...
... Organization for disAbilities Resources champions company,s effortsGAITHERSBURG, Md., ... Disability Matters Award in the category of Work ... supporting people with disabilities and their families. The ... and Springboard Consulting. The integrated food and facilities ...
... mid-level, common injury ROSEMONT, Ill., April 1 While low-level shoulder ... surgery, a literature review published in the April 2009 issue of ... ( JAAOS ) finds that many surgeons still disagree ... in between., , ...
Cached Medicine News:Health News:Drake Nabs 'Suite Deal' as Distributor of Pro:Idiom(R) Hospitality Solution to U.S. and Canadian Cable Operators 2Health News:GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US 2Health News:GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US 3Health News:GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US 4Health News:GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US 5Health News:Healing a shoulder separation 2Health News:Last step leading to blood cell formation elucidated 2Health News:Sodexo Receives 2009 Disability Matters Award 2Health News:Sodexo Receives 2009 Disability Matters Award 3Health News:Healing a Shoulder Separation 2Health News:Healing a Shoulder Separation 3
... lab with the OLA2500 High Speed Sorter ... sorting requirements. As a front-end sample-processor, the ... primary sample tubes to their destination racks ... eliminate sample-handling errors. Post-analytical archiving to any ...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Similar to Model 530, but just 37 inches long and with only one drape....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
Medicine Products: